Former Schering-Plough CEO Says This is the 'Worst Solution' to the Drug Pricing Dilemma Post author:Sam Post published:August 24, 2017 Post category:BioPharma August 25, 2017By Alex… Source: BioSpace You Might Also Like Penumbra Announces Pricing Of Offering Of 1,300,000 Shares Of Its Common Stock March 16, 2017 Ex-Employees Accuse Biotech Hedge Fund Founder of Toxic Sexual Harassment Culture December 5, 2017 NeuroDigm Uses Tissue Repair In An Innovative Nerve Pain Model May 11, 2017
